A legal challenge threatens the Pentagon's push for dual-use innovation as traditional patent protections for defense contractors may not apply to companies developing technologies for both commercial and military markets. The issue stems from 28 U.S.C. § 1498, a statute enacted over a century ago that shields contractors from patent infringement lawsuits when manufacturing products specifically for the U.S. government.
The legal uncertainty creates strategic implications for defense modernization efforts that increasingly rely on commercial technology companies. The Pentagon's emphasis on dual-use innovation aims to leverage private sector advances in artificial intelligence, semiconductors, and other critical technologies, but patent litigation risk could deter commercial firms from participating in defense programs.
The potential legal exposure may affect how technology companies structure their relationships with defense agencies and could influence vendor selection processes. Companies developing products for both commercial and government markets face unclear protection under current patent law, potentially creating competitive disadvantages for firms willing to work with the Pentagon.
The statutory immunity dates back to World War I when Franklin D. Roosevelt, serving as acting Navy secretary, warned Congress that contractors were reluctant to manufacture equipment due to patent litigation exposure. The resulting legal framework was designed for traditional defense manufacturing rather than today's dual-use technology landscape.
Legal experts suggest that clarifying patent protections for dual-use technologies could become essential as the Pentagon continues prioritizing commercial innovation partnerships to maintain technological superiority over strategic competitors.